Article
von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure.
The Journal of clinical investigation - 1 May 1993
Holmberg L, Dent J A, Schneppenheim R, Budde U, Ware J, Ruggeri Z M
Abstract excerpt
Variant von Willebrand disease designated as type I New York or type Malmö is characterized by enhanced ristocetin-induced platelet agglutination with normal von Willebrand factor multimeric distribution in plasma. We have studied four such patients belonging to three unrelated families and found in all of them a unique cytosine-to-thymine transition changing the codon for Pro503 (CCG) to Leu (CTG). In three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
